Radovan Tomic is an experienced professional in the field of market access and health economics, currently serving as the Global Market Access Director at CSL since September 2024. Prior roles include EU Market Access Director at CSL, Region Europe HTA & Reimbursement Strategy Lead at Novo Nordisk, and various positions at Novartis and Roche Pharmaceuticals, focusing on health economics, pricing, and value strategy management. Radovan holds multiple degrees, including a Master's in International Health Care Management Economics & Policy from SDA Bocconi, a Master's in Pharmaceutical Digital Marketing from Libera Università di Lingue e Comunicazione IULM, and a Master's in Pharmacy from the University of Belgrade, where Radovan also pursued a PhD in Pharmacology & Pharmacoepidemiology.
This person is not in any teams
This person is not in any offices